The ACMG Foundation for Genetic and Genomic Medicine Announces Dr. Phillip George Febbo, MD as New Board Member

News provided by

ACMG Foundation for Genetic and Genomic Medicine

Sep 27, 2018, 13:49 ET

BETHESDA, Md., Sept. 27, 2018 /PRNewswire/ -- The ACMG Foundation for Genetic and Genomic Medicine (www.acmgfoundation.org) has announced that Dr. Philip George Febbo has been elected to join its Board of Directors. The ACMG Foundation is a national nonprofit foundation dedicated to facilitating the integration of genetics and genomics into medical practice. The board members are active participants in serving as advocates for the Foundation and for advancing its policies and programs. Dr. Febbo will serve on the ACMG Foundation Board from September 2018 to September 2024.

Dr. Febbo is the Chief Medical Officer and Senior Vice-President at Illumina Inc. and previously was the Chief Medical Officer at Genomic Health, Inc. He is a former professor of Medicine, Hematology/Oncology/Urology at the University of California, San Francisco. He received his MD from the University of California, San Francisco, completed his residency at Brigham and Women's Hospital in Boston and post-doctoral fellowship at Dana-Farber Cancer Institute. Dr. Febbo was also the Co-Director at UCSF Helen Diller Family Comprehensive Cancer Center, Prostate Cancer program from 2010-2013. He has over 100 manuscripts and book chapters focused on the application of genomics to understand the biology and clinical behavior of cancer and has served on a number of editorial boards including the Journal of Oncology, Clinical Oncology, Future Oncology, and Case Reports in Medicine. Dr. Febbo has received a number of honors and awards including the NIH Funding through RO! and U01 grants, a Prostate Cancer Foundation Challenge Award, the Damon Runyon Cancer Research Foundation Clinical Investigator Award, and several Department of Defense awards including a New Investigator Award, Idea Development Award and Physician Research Training Award.

"Dr. Febbo brings to ACMGF outstanding experience and insights into cutting edge applications in genomic medicine. His guidance and expertise will be instrumental in helping to guide the Foundation's efforts in this critical area of the mission of ACMG," said Bruce R. Korf, MD, PhD, FACMG, president of the ACMG Foundation.

"It is an honor to serve on the board of the ACMG Foundation," said Dr. Febbo. "As genetics and genomics are becoming increasingly part of understanding human health and disease, I am excited to contribute to the activities of ACMG Foundation and their critical support of the core mission of the ACMG and its members. Through professional guidelines, continuing education, research, and training, the ACMG has incredibly important responsibilities in the era of precision medicine."

The complete list of the ACMG Foundation Board of Directors is at www.acmgfoundation.org.

About the ACMG Foundation for Genetic and Genomic Medicine

The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics in healthcare. Established in 1992, the ACMG Foundation for Genetic and Genomic Medicine supports the American College of Medical Genetics and Genomics' mission to "translate genes into health" by raising funds to attract the next generation of medical geneticists and genetic counselors, to sponsor important research, to promote information about medical genetics, and much more.

To learn more about the important mission and projects of the ACMG Foundation for Genetic and Genomic Medicine and how you too can support this great cause, please visit www.acmgfoundation.org or contact Nicole Bell, ACMG Foundation Manager at [email protected] or 301-718-2014.

Media Contact: Kathy Moran, MBA
[email protected]

SOURCE ACMG Foundation for Genetic and Genomic Medicine